Shares of Evoke plc (LON:EVOK – Get Free Report) dropped 10% during mid-day trading on Friday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares were traded during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
Several equities analysts have commented on the company. Berenberg Bank cut their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research report on Wednesday, December 4th. Jefferies Financial Group restated a “buy” rating and issued a GBX 140 ($1.81) price target on shares of Evoke in a report on Monday, December 16th.
Get Our Latest Research Report on Evoke
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, research analysts predict that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insiders Place Their Bets
In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of Evoke stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is owned by company insiders.
About Evoke
Featured Articles
- Five stocks we like better than Evoke
- What is a buyback in stocks? A comprehensive guide for investors
- MarketBeat Week in Review – 03/24 – 03/28
- Are Penny Stocks a Good Fit for Your Portfolio?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.